2025 New Drug Update Part 1 & 2
Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP
“
”Fantastic presentation! So much great information. Wayne is brilliant!”
”Dr. Weart is amazing! I learned so much!
”Dr Weart is a phenomenal expert. Highly enjoyed this conference.”
”Thoroughly enjoyed Wayne! What a gift that he’s still enjoys sharing his vast knowledge with all of us.”
”Excellent review of important disease states, therapies, pharmacology, and pertinent studies that relate to those disease states.”
”Dr. Weart gave an excellent presentation. His overview was right on point, and I can’t wait to attend another one of his presentations.”
About This Course
Recorded April 24, 2025 and valid to April 24, 2028
Price $200 for 10 Hours
ON DEMAND 2025-04-24:New Drug Update Part 1 & 2
Learning Objectives
Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
Describe their adverse effects and drug interaction that may affect patient compliance.
Compare efficacy, dosage and cost to existing agent
Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.
Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.
Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP
Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.
Accreditation Information
PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists. On-demand courses provide HOME STUDY credit only.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS: This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).
NURSES: University Learning Systems is Approved by the California Board of Registered Nursing, Provider Number CEP 11409, CE Broker: Arkansas, District of Columbia, Florida, Georgia, Kentucky, New Mexico, and West Virginia, Boards of Nursing.
PHYSICIANS: This CME program offers Category 2 credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive MAINPRO-M2 credits for participation in this activity.
PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval